Brings leading CNS products, including a product for the treatment of relapsing multiple sclerosis, to new territories Dubai, UAE – 1st October, 2024 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the launch of Neuraxpharm Middle East to cover the six members … Continue reading Neuraxpharm expands operations into the Middle East